Market cap
₹570 Cr
Revenue (TTM)
₹1,718 Cr
P/E Ratio
12.3
P/B Ratio
1.6
Div. Yield
7 %
| KSE | Godrej Agrovet | Narmada Agrobase | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
570 | 12,289 | 87 | 55 | 39 |
Revenue (₹ Cr) |
1,718 | 10,474 | 90 | 213 | 1 |
Net Profit (₹ Cr) |
46.43 | 384.15 | 3.59 | 4.66 | -0.40 |
Net Margin (%) |
2.68 | 3.63 | 3.96 | 2.18 | -40.89 |
RoE (%) |
13.15 | 24.56 | 6.13 | 5.10 | -- |
Price to Earnings |
12.27 | 27.51 | 24.18 | 11.70 | -- |
Price-To-Book |
1.63 | 5.75 | 1.45 | 0.59 | 1.72 |
Income Statement (₹ Cr)
| KSE | Godrej Agrovet | Narmada Agrobase | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
|
Operating Revenue
|
1,718.16 | 10,473.61 | 89.58 | 212.73 | 0.85 |
|
Total Income
|
1,732.44 | 10,582.34 | 90.80 | 213.79 | 0.97 |
|
Total Expenditure
|
1,658.60 | 9,639.56 | 84.97 | 203.49 | 1.24 |
|
EBITDA
|
59.55 | 834.05 | 4.60 | 9.24 | -0.39 |
|
Depreciation
|
8.30 | 227.64 | 0.22 | 2.68 | 0.00 |
|
EBIT
|
51.26 | 606.41 | 4.38 | 6.56 | -0.39 |
|
Interest
|
2.62 | 132.57 | 0.75 | 1.02 | 0.00 |
|
Other Income
|
14.29 | 108.73 | 1.23 | 1.06 | 0.12 |
|
Exceptional Items
|
0.47 | -30.44 | 0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
63.40 | 552.13 | 4.85 | 6.60 | -0.28 |
|
Provision for Tax
|
16.97 | 167.98 | 1.26 | 1.94 | 0.12 |
|
Profit after Tax
|
46.43 | 384.15 | 3.59 | 4.66 | -0.40 |
Liabilities (₹ Cr)
| KSE | Godrej Agrovet | Narmada Agrobase | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
349.50 | 2,032.08 | 59.34 | 91.62 | 15.41 |
|
Minority Interest
|
0.00 | 22.10 | 0.00 | 0.00 | 0.00 |
|
Non-Current Liabilities
|
23.95 | 1,077.70 | 1.02 | 1.71 | 0.00 |
|
Current Liabilities
|
41.53 | 2,928.83 | 11.90 | 31.57 | 0.20 |
|
Total Liabilities
|
414.98 | 6,160.85 | 72.25 | 120.37 | 15.61 |
Assets (₹ Cr)
| KSE | Godrej Agrovet | Narmada Agrobase | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
62.88 | 2,894.61 | 11.15 | 32.71 | 0.15 |
|
Current Assets
|
349.72 | 2,758.50 | 60.54 | 74.47 | 15.46 |
|
Total Assets
|
414.98 | 6,160.85 | 72.25 | 120.37 | 15.61 |
|
Total Debt*
|
24.87 | 1,468.43 | 10.10 | 17.76 | 0.00 |
|
Net Current Assets
|
308.19 | -170.33 | 48.64 | 42.90 | 15.26 |
|
Contingent Liabilities
|
1.86 | 164.76 | 0.05 | -- | -- |
Cashflow (₹ Cr)
| KSE | Godrej Agrovet | Narmada Agrobase | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
53.52 | 1,281.17 | -1.30 | -5.73 | 0.00 |
|
Cash Flow from Investing Activities
|
-8.92 | -150.39 | -2.95 | -15.77 | -- |
|
Cash from Financing Activities
|
-33.22 | -868.90 | -0.18 | 15.09 | 0.00 |
|
Net Cash Inflow / Outflow
|
11.38 | 261.88 | -4.43 | -6.41 | 0.00 |
Ratios
Profitability Ratios
| KSE | Godrej Agrovet | Narmada Agrobase | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
|
ROCE (%)
|
33.62 | 20.95 | 8.94 | 6.53 | 2.84 |
|
ROE (%)
|
13.15 | 24.56 | 6.13 | 5.10 | 2.09 |
|
ROA (%)
|
12.03 | 6.57 | 5.18 | 4.15 | -2.55 |
|
EBIT Margin (%)
|
2.98 | 5.79 | 4.89 | 3.09 | -46.02 |
|
Net Margin (%)
|
2.68 | 3.63 | 3.96 | 2.18 | -40.89 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| KSE | Godrej Agrovet | Narmada Agrobase | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
5.14 | 8.58 | 38.88 | 76.83 | -60.44 |
|
EBIT Growth (%)
|
-62.97 | -3.80 | -13.77 | 181.11 | -159.28 |
|
Net Profit Growth (%)
|
-58.35 | 3.76 | -12.13 | 27.00 | -156.63 |
|
EPS Growth (%)
|
-95.80 | 3.67 | -44.00 | 27.00 | -152.06 |
|
Book Value Growth (%)
|
17.78 | -14.87 | 6.21 | 3.69 | 2.11 |
Valuation Ratios
| KSE | Godrej Agrovet | Narmada Agrobase | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
|
Price / Earnings
|
12.36 | 26.03 | 12.09 | 11.12 | -48.20 |
|
Price / Book Value
|
1.63 | 5.75 | 1.45 | 0.59 | 1.72 |
|
Dividend Yield (%)
|
7.02 | 1.72 | 0.00 | 0.00 | 0.00 |
|
EV/EBITDA
|
6.80 | 16.12 | 18.82 | 7.78 | -100.99 |
|
Market Cap (₹ Cr)
|
564.14 | 10,276.68 | 115.67 | 66.15 | 15.29 |
Solvency Ratios
| KSE | Godrej Agrovet | Narmada Agrobase | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.05 | 0.40 | 0.02 | 0.02 | 0.00 |
|
Short term debt to equity ratio
|
0.00 | 0.19 | 0.15 | 0.18 | -- |
|
Current Ratio
|
8.42 | 0.94 | 5.09 | 2.36 | 77.30 |
|
Quick Ratio
|
4.97 | 0.48 | 3.90 | 1.03 | 43.45 |
|
Interest Coverage
|
25.24 | 5.16 | 7.46 | 7.47 | -92.00 |
Operating Efficiency Ratios
| KSE | Godrej Agrovet | Narmada Agrobase | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
0.06 | 6.42 | 39.49 | 7.78 | 460.54 |
|
Asset Turnover
|
4.45 | 1.79 | 1.29 | 1.89 | 0.05 |
|
Receivable days
|
0.29 | 21.15 | 126.71 | 34.07 | 561.48 |
|
Inventory Days
|
27.72 | 44.46 | 87.41 | 63.48 | 1,011.41 |
|
Payable days
|
2.46 | 31.76 | 3.90 | 15.31 | 28.80 |
|
Cash Conversion Cycle
|
25.54 | 33.86 | 210.22 | 82.25 | 1,544.08 |